|1.||Xu, Dongqing: 1 article (09/2014)|
|2.||Liu, Yuhong: 1 article (09/2014)|
|3.||Wang, Fengshan: 1 article (09/2014)|
|4.||Zhang, Xinke: 1 article (09/2014)|
|5.||Tan, Haining: 1 article (09/2014)|
|6.||Cheng, Yanna: 1 article (09/2014)|
|7.||Yin, Fengxin: 1 article (09/2014)|
|8.||Li, Pingli: 1 article (09/2014)|
|9.||Heinig, Lars: 1 article (01/2013)|
|10.||Ichiyama, Koji: 1 article (01/2013)|
09/22/2014 - "Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant."
01/01/2013 - "Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application."
12/15/1996 - "A sulfated polysaccharide, curdlan sulfate (CRDS) with 1,3-beta-D-glucan as a main chain, inhibits HIV-1 infection of human peripheral blood lymphocytes (PBLs) by binding to the V3 region of gp 120. "
12/15/1996 - "Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes."
08/01/1994 - "Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro."
|3.||HIV Infections (HIV Infection)
06/09/1992 - "This anti-HIV activity was close to the EC50 of 0.43 microgram/mL for a highly active sulfated polysaccharide curdlan sulfate which was reported to inhibit completely the HIV infection at a concentration as low as 3.3 micrograms/mL. These compounds were also active against HIV-2 and a clinically isolated HIV-1 with reduced AZT sensitivity. "
04/15/2001 - "Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection."
06/01/1998 - "The blocking effect of curdlan sulfate (CRDS) on human immunodeficiency virus (HIV) infection has been thought to be related to inhibition of the binding of HIV-1 envelope glycoprotein (gp120) and CD4 molecules. "
|2.||Hepatitis B Surface Antigens (HBsAg)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)